Docoh
Loading...

CHMA Chiasma

Employees

Data from SEC filings
Employee count

ESG framework mentions

In last year of SEC filings
Sustainability Accounting Standards Board (SASB)
No mentions
Global Reporting Initiative (GRI)
No mentions
Task Force on Climate-related Financial Disclosures (TCFD)
No mentions
UN Sustainable Development Goals (SDGs)
No mentions

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM
On August 3, 2021, Chiasma, Inc. (“Chiasma”) held a virtual special meeting of its stockholders (the “Special Meeting”). Chiasma’s stockholders voted on Proposal 1 and Proposal 2 at the Special Meeting, which are described in more detail in the definitive proxy statement filed by Chiasma with the U.S. Securities and Exchange Commission on July 2, 2021.

Chiasma’s stockholders were entitled to one vote for each share of common stock, $0.01 par value per share (each, a “Share”), held as of the close of business on June 15, 2021 (the “Record Date”). At the close of business on the Record Date, there were 63,191,027 Shares entitled to vote at the Special Meeting. Present at the Special Meeting or by proxy were holders of 40,381,618 Shares, representing 63.88% of the outstanding Shares eligible to vote at the Special Meeting, and constituting a quorum. The final results with respect to such proposal are set forth below.

Proposal 1 – The Merger Proposal. To adopt the Agreement and Plan of Merger, dated as of May 4, 2021 (the “Merger Agreement”) by and among Chiasma, Amryt Pharma plc (“Amryt”) and Acorn Merger Sub, Inc., an indirect wholly owned subsidiary of Amryt (“Merger Sub”), pursuant to which Merger Sub will merge with and into Chiasma (the “Merger”), with Chiasma surviving the merger as an indirect wholly owned subsidiary of Amryt.

Votes For Votes AgainstAbstentionsBroker Non-Votes
40,122,701246,78912,128


Proposal 2 – The Advisory, Non-Binding Compensation Proposal. To approve, on a non-binding advisory basis, the compensation that may be paid or become payable to Chiasma’s named executive officers that is based on or otherwise relates to the transactions contemplated by the merger agreement.

Votes For Votes AgainstAbstentionsBroker Non-Votes
36,757,866517,9493,105,803


Stockholder action on a third proposal, to approve the adjournment of the Special Meeting, if necessary or appropriate, to solicit additional proxies in favor of approving the Merger Proposal, was not required in light of the adoption of the Merger Proposal and no vote was taken on that proposal.